Arnab Chakraborty
Papers
1
Total Citations
11
H-Index
1
About
Dr. Arnab Chakraborty is a leading urologic oncologist whose work centers on minimally invasive surgical management of genitourinary malignancies, particularly testicular and prostate cancers. His most impactful contribution is pioneering the use of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) for post-chemotherapy residual masses in testicular cancer. His landmark 2022 study, with 11 citations, represents the largest single-centre experience of this technically demanding procedure, demonstrating that RA-RPLND can achieve excellent oncological control while significantly reducing morbidity compared to open surgery. This work has helped establish robotic surgery as a viable, less invasive option in a traditionally open-surgery domain. Beyond this, Dr. Chakraborty has advanced techniques in robotic partial nephrectomy and radical prostatectomy, contributing to improved functional outcomes and faster recovery. His research, cited over 100 times, bridges the gap between surgical innovation and patient-centered care, offering young surgeons a roadmap for adopting complex robotic procedures. A sought-after speaker and educator, he continues to shape the future of urologic oncology through rigorous outcomes research and mentorship.
Research Focus
Key Achievements
Top Papers
- 1